STI571:: Bcr-Abl kinase inhibition as the basis of therapy for CML

被引：0
|
作者：
Mauro, MJ [1 ]
Druker, BJ [1 ]
机构：
[1] Oregon Hlth Sci Univ, Portland, OR 97201 USA
来源：
LEUKEMIA | 2001年 / 15卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O23
引用
收藏
页码：488 / 488
页数：1
相关论文
共 50 条
  • [21] STI571 reverses the mutator phenotype induced by Bcr-Abl in murine cell lines.
    van der Kuip, H
    Miething, C
    Duyster, J
    Aulitzky, WE
    BLOOD, 2001, 98 (11) : 571A - 571A
  • [22] Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response to STI571 in chronic phase CML patients.
    Merx, K
    Kreil, S
    Lahaye, T
    Müller, MC
    Paschka, P
    Schoch, C
    Weisser, A
    Kuhn, C
    Landmann, T
    Gschaidmeier, H
    Berger, U
    Hehlmann, R
    Hochhaus, A
    BLOOD, 2001, 98 (11) : 846A - 847A
  • [23] Detection of resistance to STI571 in patients with BCR-ABL positive acute leukemia and chronic myeloid leukemia (CML) blast crisis.
    Mahon, FX
    Belloc, F
    Cholet, C
    Cony-Makhoul, P
    Guilhot, F
    Melo, JV
    Berthaud, P
    Reiffers, J
    BLOOD, 2000, 96 (11) : 471A - 471A
  • [24] Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML
    Brian J Druker
    Oncogene, 2002, 21 : 8541 - 8546
  • [25] Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML
    Druker, BJ
    ONCOGENE, 2002, 21 (56) : 8541 - 8546
  • [26] Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, STI 571
    Kitiyakara, C
    Atichartakarn, V
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (04) : 685 - 687
  • [27] Serial molecular monitoring of BCR-ABL using quantitative real-time RT-PCR in patients with CML during therapy with STI571 (Glivec).
    Neumann, F
    Herold, C
    Habersang, K
    Kobbe, G
    Haas, R
    Gattermann, N
    Kronenwett, R
    BLOOD, 2002, 100 (11) : 332B - 332B
  • [28] Phosphorylation of Bcr-Abl kinase and its downstream substrates in response to STI571 treatment in human chronic myelogenous leukemia cells
    不详
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S465 - S465
  • [29] Multiple BCR-ABL copies on duplicated Philadelphia chromosomes point to an active gene amplification mechanism in an STI571 treated CML patient.
    Rieder, H
    Wündisch, T
    Bachmann, I
    Neubauer, A
    BLOOD, 2001, 98 (11) : 194B - 194B
  • [30] The kinase inhibitor STI571 reverses the Bcr-Abl induced point mutation frequencies observed in pre-leukemic P190Bcr-Abl transgenic mice
    Brain, JM
    Saksena, A
    Laneuville, P
    LEUKEMIA RESEARCH, 2002, 26 (11) : 1011 - 1016
12345